Actively Recruiting
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
Led by National Taiwan University Hospital · Updated on 2025-12-22
600
Participants Needed
1
Research Sites
274 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective observational study on the clinical characteristics of pulmonary graft-versus-host disease in patients after hematopoietic stem cell transplantation.
CONDITIONS
Official Title
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Patients scheduled to receive their first allogeneic hematopoietic stem cell transplantation
You will not qualify if you...
- Respiratory failure
- Hemodynamic instability
- Presence of pneumothorax or bronchial fistula
- Acute coronary syndrome within the past month
- Inability to walk more than 20 meters
- Severe lower-limb joint disease
- Inability to cooperate with study procedures
- Requirement for all-day oxygen supplementation
- Previous lung transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
T
Ting-Yu Liao
CONTACT
Z
Zong-Han Yao
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here